Milestone Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 10, 2023 at 07:28 am EDT
Milestone Pharmaceuticals Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 16.04 million compared to USD 16.65 million a year ago. Basic loss per share from continuing operations was USD 0.37 compared to USD 0.39 a year ago.
For the six months, sales was USD 1 million. Net loss was USD 30.99 million compared to USD 30.66 million a year ago. Basic loss per share from continuing operations was USD 0.72 compared to USD 0.73 a year ago.